AstraZeneca has terminated all development of vemircopan, the oral factor D inhibitor it acquired through the deal for Alexion in 2021. The UK major recorded an impairment charge of $753 million as a ...
Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
The firm scrapped its £450m investment despite the government's offer of support, the government says.
A planned investment deal between the Government and AstraZeneca is not going ahead because it did not “add up for the UK ...
(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...
Shares of the British-Swedish pharmaceutical titan AstraZeneca are trading 7% lower in London today as investors price in the acquisition of Alexion Pharmaceuticals for $39 billion. A deal, which is ...
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW ...
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW/ - ...
A board member at TikTok’s parent company said that a deal to save the app from disappearing in the United States will be done soon. General Atlantic CEO Bill Ford, a ByteDance board member ...
Monopar Therapeutics Inc (MNPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Sean Lee from Citi maintained a Buy rating on the ...
The president wants to begin renegotiating a U.S. trade deal with Canada and Mexico earlier than a scheduled 2026 review, people familiar with his thinking said. By Ana Swanson Ana Swanson has ...